摘要：

Focuses on a study which investigated whether the level of protective adipocytokine could be increased by treatment with a peroxisome proliferator-activated receptor-gamma agonist in diabetic patients. Research design and methods; Changes of characteristics from baseline to six months after treatment with either rosiglitazone in 30 subjects or placebo on 34 subjects; Conclusion.

展开